2519. A Multi-national Phase 3, Randomized, Double-Blind, Active Comparator-Controlled Clinical Trial to Study the Safety, Tolerability, and Efficacy of Imipenem/Cilastatin/Relebactam (MK-7655A) Versus Piperacillin/Tazobactam in Subjects with Hospital-Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia

Junjie Li, Wei Feng,Xiang Peng, Zhen-Gang Tang,Lianshu Ding,Maria C Losada, Zlatka Iamboliyska, Ming-fen Zhu, Xiaodan Guo, Xiaoling Du, Chen Chang, Luke Francis Chen,Min Zhou,Jieming Qu

Open Forum Infectious Diseases（2023）

Cited 0|Views4

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined